Definium Therapeutics (DFTX) EPS (Basic) Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,207.14% |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | -162.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162.96% |
| Dec 31, 2025 | -19.05% |
| Sep 30, 2025 | -333.33% |
| Jun 30, 2025 | -525.00% |
| Mar 31, 2025 | 76.32% |
| Dec 31, 2024 | 28.81% |
| Sep 30, 2024 | 60.00% |
| Jun 30, 2024 | 89.47% |
| Mar 31, 2024 | -75.38% |
| Dec 31, 2023 | -2,850.00% |
| Sep 30, 2023 | 19.64% |
| Jun 30, 2023 | -26.67% |
| Mar 31, 2023 | 1.52% |
| Dec 31, 2022 | 96.61% |
| Sep 30, 2022 | 8.20% |
| Jun 30, 2022 | -445.45% |
| Mar 31, 2022 | -1,550.00% |
| Dec 31, 2021 | -1,375.00% |
| Sep 30, 2021 | -2,133.33% |
| Jun 30, 2021 | -650.00% |
| Mar 31, 2021 | -33.33% |
| Dec 31, 2020 | 60.00% |